Opko Health (OPK) Depreciation & Amortization (CF) (2016 - 2025)
Opko Health's Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $22.4 million for Q4 2025.
- For Q4 2025, Depreciation & Amortization (CF) changed N/A year-over-year to $22.4 million; the TTM value through Dec 2025 reached $91.6 million, up 23.59%, while the annual FY2025 figure was $91.6 million, 6.67% down from the prior year.
- Depreciation & Amortization (CF) reached $22.4 million in Q4 2025 per OPK's latest filing, down from $22.7 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $28.0 million in Q2 2022 to a low of $19.0 million in Q3 2021.
- Average Depreciation & Amortization (CF) over 5 years is $24.2 million, with a median of $24.2 million recorded in 2024.
- Peak YoY movement for Depreciation & Amortization (CF): dropped 9.85% in 2021, then soared 47.63% in 2022.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $19.2 million in 2021, then surged by 37.88% to $26.5 million in 2022, then decreased by 1.81% to $26.0 million in 2023, then decreased by 7.0% to $24.2 million in 2024, then fell by 7.41% to $22.4 million in 2025.
- Per Business Quant, the three most recent readings for OPK's Depreciation & Amortization (CF) are $22.4 million (Q4 2025), $22.7 million (Q3 2025), and $23.0 million (Q2 2025).